Loading...
About Us 2019-07-18T16:53:29+00:00

rapiplex

Formed in 2009, Biosensia is a science focused, venture backed business established specifically to develop and exploit this novel and proprietary technology, RapiPlex. Biosensia is interested in exploring product commercialisation under license agreement.

The company has core skills in immunology, biochemistry,  microbiology, physics, microfluidics, design engineering, software development and quality/regulatory affairs. Our aim is to make RapiPlex a method of choice for testing multiple analytes in a matter of minutes.

The Biosensia Team

Our management and advisory team have a proven track record
in taking novel products to successful commercialisation

Niamh O’LuanaighChief Operating Officer
Niamh joined Biosensia in 2011, having previously worked for BBInternational (Alere) for 11 years. Responsible for development of multiple rapid tests and established BBI’s first site outside UK, in USA for development and manufacture of rapid tests.
Daniel MillsProject Manager and Product Development Scientist
Daniel first joined Biosensia in 2016 and has worked on a number of product development projects from Proof of Concept for RapiPlex. Between April 2018 and June 2019, Daniel worked as Senior Product Development Scientist for a veterinary diagnostics company, expanding their test menu and the development of single target reader platform. Daniels experience has been centred on the development of lateral flow assays across multiple platforms and in the maintenance and QMS management.
Dieudonne SidiSenior Product Development Scientist
Dieudonne joined Biosensia in 2016 as Product Development Scientist bringing with him substantial experience in lateral flow assay development from Trinity Biotech Ltd. and EKF Diagnostics Ltd. He is a qualified Medical Laboratory Scientist with 5 years’ experience in a clinical facility in Cameroon. He has thorough knowledge in Elisa, Western Blotting, PCR and other Bio-analytical techniques.
Ronan ShanughessySenior Product Development Scientist
Ronan joined Biosensia in 2017 when he was awarded a one-year Industry Fellowship by Science Foundation Ireland (SFI). This grant was a collaboration between the company and University College Dublin to develop lateral flow assays to detect microRNAs of diagnostic importance for Tuberculosis. Ronan has a PhD in Immunology and a total of 10 years’ experience researching infectious diseases that has resulted in expertise with a wide range of cellular and molecular techniques.
Shane KearneyProduct Development Scientist
BSc (Honours) Bioanalytical Sciences, Institute of Technology Tallaght, Dublin. Shane joined Biosensia-Kypha in 2018 having worked for a number of years in both clinical and environmental diagnostic companies in Dublin. He has experience developing and manufacturing rapid tests both for visual and platform based applications.
Lorna TierneyProduct Development Scientist
BSc (Honours) Biological and Biomedical Sciences from NUI Maynooth, Ireland. Following further post-graduate research and training at NUI Maynooth, Lorna joined Biosensia in 2014 and has worked on developing multiple rapid tests for reader based platforms. Lorna is also a trained phlebotomist.
Deirdre BarryOffice Manager
30 years administrative experience. Worked in a University Teaching Hospital, the Pharmaceutical Industry, the Medical Device Industry developing standards of practice. Qualifications in Training Delivery and Personnel Management. Worked with Biosensia since start up.